547A Stock Overview
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 547A from our risk checks.
Ambu A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.14.38 |
| 52 Week High | kr.16.80 |
| 52 Week Low | kr.8.76 |
| Beta | 0.87 |
| 1 Month Change | -4.55% |
| 3 Month Change | -2.18% |
| 1 Year Change | 1.41% |
| 3 Year Change | -69.02% |
| 5 Year Change | -40.28% |
| Change since IPO | -51.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| 547A | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0.3% | 4.0% | 2.0% |
| 1Y | 1.4% | -8.3% | 2.0% |
Return vs Industry: 547A exceeded the German Medical Equipment industry which returned -8.4% over the past year.
Return vs Market: 547A matched the German Market which returned 1.3% over the past year.
Price Volatility
| 547A volatility | |
|---|---|
| 547A Average Weekly Movement | 5.1% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 547A has not had significant price volatility in the past 3 months.
Volatility Over Time: 547A's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 4,600 | Britt Jensen | www.ambu.com |
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Ambu A/S Fundamentals Summary
| 547A fundamental statistics | |
|---|---|
| Market cap | €3.95b |
| Earnings (TTM) | €31.92m |
| Revenue (TTM) | €656.82m |
123.7x
P/E Ratio6.0x
P/S RatioIs 547A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 547A income statement (TTM) | |
|---|---|
| Revenue | kr.4.90b |
| Cost of Revenue | kr.2.11b |
| Gross Profit | kr.2.79b |
| Other Expenses | kr.2.55b |
| Earnings | kr.238.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | 0.89 |
| Gross Margin | 56.97% |
| Net Profit Margin | 4.86% |
| Debt/Equity Ratio | 0% |
How did 547A perform over the long term?
See historical performance and comparison